Stock gainers:Stock decliners:. Here are some of the biggest movers on Monday:.
Stock gainers:Stock decliners:... Here are some of the biggest movers on Monday:
Source: News Formal (newsformal.com)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck in late-stage talks to acquire Prometheus Biosciences -WSJMerck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter. Ain't that an ominous name... Next...for your Best Passively Income! fintoch ! Welcome! Best daily income With Blockchain Fintoch 1-1.5% daily with Compounding System Register! Cp:+62 81240825169
Source: Reuters - 🏆 2. / 97 Read more »
Merck to buy Prometheus Biosciences for about $11 blnMerck & Co has agreed to acquire Prometheus Biosciences Inc for about $10.8 billion to bolster the company's presence in immunology, the companies said on Sunday.
Source: Reuters - 🏆 2. / 97 Read more »
Merck in talks to acquire Prometheus Biosciences: reportMerck is reportedly in talks to buy the San Diego-based Prometheus Biosciences in a promising deal that could be announced as early as Sunday. Prometheus? 🤨 Ever wonder why it is that science seems to always involve biblical and/or ancient names? Why is that I wonder? 🤔🧐
Source: FoxBusiness - 🏆 458. / 53 Read more »
Merck to buy Prometheus Biosciences for about $11 billionMerck has agreed to acquire Prometheus Biosciences for about $10.8 billion to bolster the company's presence in immunology, the companies said on Sunday. How much did Nancy make off this
Source: CNBC - 🏆 12. / 72 Read more »
Merck to acquire Prometheus Biosciences for $10.8BMerck is acquiring San Diego-based Prometheus Biosciences in a $10.8 billion deal.
Source: FoxBusiness - 🏆 458. / 53 Read more »
Merck to buy Prometheus Biosciences for $10.8 billionMerck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or about $10.8 billion. Any company named after a Movie is a fraud. Of course they would. The of people with autoimmune diseases is growing rapidly after C19 vax. I’m completely against the vax and surrounding areas of big pharma but I invested a small amount into Merck at 79$ mark. I’m up 45% already!
Source: MarketWatch - 🏆 3. / 97 Read more »